Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease
Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki di...
Saved in:
Published in | Clinical immunology (Orlando, Fla.) Vol. 171; pp. 25 - 31 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.10.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8+HLA-DR+ T cells. There was a significant difference in the ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8+ T cell activation, as well as an imbalance between CD8+ T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8+ HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8+ T cell activation, but excessive CD8+ T cell activation may cause IVIG resistance. The ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity.
•An imbalance in CD8+ T cell activation and inhibition are important in the pathogenesis of Kawasaki disease.•The percentage of CD8+HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease.•IVIG inhibits CD8+ T cell activation, but if the level of CD8+ T cell activation is too high, IVIG resistance may result.•The ratio of CD3+CD8+HLA-DR+ T cells/CD3+CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity. |
---|---|
AbstractList | Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8+HLA-DR+ T cells. There was a significant difference in the ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8+ T cell activation, as well as an imbalance between CD8+ T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8+ HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8+ T cell activation, but excessive CD8+ T cell activation may cause IVIG resistance. The ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity. Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8+HLA-DR+ T cells. There was a significant difference in the ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8+ T cell activation, as well as an imbalance between CD8+ T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8+ HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8+ T cell activation, but excessive CD8+ T cell activation may cause IVIG resistance. The ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity.Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8+HLA-DR+ T cells. There was a significant difference in the ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8+ T cell activation, as well as an imbalance between CD8+ T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8+ HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8+ T cell activation, but excessive CD8+ T cell activation may cause IVIG resistance. The ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity. Abstract Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4 + and CD8 + T cells during the acute phase of KD. We compared the percentages of HLA-DR +/CD69 +/CD25 + T cells in the CD4 + and CD8 + T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8 + HLA-DR + T cells and the median ratio of CD8 + HLA-DR + T cells/CD8 + CD25 + T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8 + HLA-DR + T cells. There was a significant difference in the ratio of CD8 + HLA-DR + T cells/CD8 + CD69 + T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8 + T cell activation, as well as an imbalance between CD8 + T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8 + HLA-DR + T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8 + T cell activation, but excessive CD8 + T cell activation may cause IVIG resistance. The ratio of CD8 + HLA-DR + T cells/CD8 + CD69 + T cells may be used as a predictor of IVIG sensitivity. Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults. However, Kawasaki disease lacks specific laboratory diagnostic indices. Thus, this study analyzed the T cell activation profiles of Kawasaki disease and assessed their value in the diagnosis of Kawasaki disease and the prediction of intravenous immunoglobulin (IVIG) sensitivity. We analyzed human leukocyte antigen-DR (HLA-DR), CD69 and CD25 expression on peripheral blood CD4+ and CD8+ T cells during the acute phase of KD. We compared the percentages of HLA-DR+/CD69+/CD25+ T cells in the CD4+ and CD8+ T cell populations of IVIG-effective and IVIG-resistant groups. Receiver operating characteristic curves were used to assess the diagnostic value of the above parameters. The median percentage of CD8+HLA-DR+ T cells and the median ratio of CD8+HLA-DR+ T cells/CD8+CD25+ T cells were significantly elevated in the patient group compared with those in the control group during the acute phase of KD. Regarding the diagnosis of Kawasaki disease, the area under the ROC curve was 0.939 for the percentage of CD8+HLA-DR+ T cells. There was a significant difference in the ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells between IVIG-resistant patients and IVIG-sensitive patients. Regarding IVIG sensitivity, the area under the ROC curve was 0.795 for it. Excessive CD8+ T cell activation, as well as an imbalance between CD8+ T cell activation and inhibition, underlies the pathogenesis of Kawasaki disease. The percentage of CD8+ HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease. IVIG inhibits CD8+ T cell activation, but excessive CD8+ T cell activation may cause IVIG resistance. The ratio of CD8+HLA-DR+ T cells/CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity. •An imbalance in CD8+ T cell activation and inhibition are important in the pathogenesis of Kawasaki disease.•The percentage of CD8+HLA-DR+ T cells may be used as an index to diagnose Kawasaki disease.•IVIG inhibits CD8+ T cell activation, but if the level of CD8+ T cell activation is too high, IVIG resistance may result.•The ratio of CD3+CD8+HLA-DR+ T cells/CD3+CD8+CD69+ T cells may be used as a predictor of IVIG sensitivity. |
Author | Gong, Fang-qi Hu, Jian Ye, Qing Shang, Shi-qiang |
Author_xml | – sequence: 1 givenname: Qing surname: Ye fullname: Ye, Qing organization: Zhejiang Key Laboratory for Neonatal Diseases, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, PR China – sequence: 2 givenname: Fang-qi surname: Gong fullname: Gong, Fang-qi email: gongfangqi63@gmail.com organization: Department of Cardiology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, PR China – sequence: 3 givenname: Shi-qiang surname: Shang fullname: Shang, Shi-qiang email: qingye@zju.edu.cn organization: Zhejiang Key Laboratory for Neonatal Diseases, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, PR China – sequence: 4 givenname: Jian surname: Hu fullname: Hu, Jian organization: Department of Cardiology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, PR China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27519954$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkktv1DAUhS1URB_wB1ggL5HQBD9iO2GBVA0UKiqxoKwtx7kpnib2YDtT9d_jdKYbJCpWtqXvHNvn3FN05IMHhF5TUlFC5ftNZUc3VazsK9JUhLJn6IQKRleKcHF02EtJ5TE6TWlDCBGMyRfomClB21bUJ-ju0udoduDDnLCbptmHmzF08-g8zhFMnsBnHCFtg0-ucJAS7mELvk84FOYXlONNBMBhwOtPzTt8jS2MIzY2u53JrkDF65u5M8ncOty7BCbBS_R8MGOCV4f1DP28-Hy9_rq6-v7lcn1-tbJ1zfKqhabnqqHEDKQ2IFlnSU8oqdUwyH4QnAkGteVNX8tO2Y6ZztChpapt6o4Yxc_Q273vNobfM6SsJ5eW9xkP5cuaNlyxVjIu_gcVvFW05QV9c0DnboJeb6ObTLzXj7kWoNkDNoaUIgzauvwQRknbjZoSvVSoN3qpUC8VatLoUmGRsr-kj-5Pij7uRVCy3DmIC-KdNeMt3EPahDn6ErOmOjFN9I9lMpbBoJITVsaiGHz4t4Hug3vq9j_SD8mi |
CitedBy_id | crossref_primary_10_1093_jpids_piaa162 crossref_primary_10_1186_s12969_020_0420_8 crossref_primary_10_3389_fped_2020_00148 crossref_primary_10_1097_INF_0000000000003144 crossref_primary_10_1186_s12865_018_0282_8 crossref_primary_10_1007_s00246_024_03657_9 crossref_primary_10_3389_fimmu_2024_1457687 crossref_primary_10_1097_BOR_0000000000000447 crossref_primary_10_1016_j_imlet_2024_106948 crossref_primary_10_1016_j_autrev_2020_102554 crossref_primary_10_1038_s41598_021_96632_w crossref_primary_10_1093_rheumatology_keac250 crossref_primary_10_2147_JIR_S468472 crossref_primary_10_2147_PHMT_S489512 crossref_primary_10_1016_j_cellimm_2022_104554 crossref_primary_10_7717_peerj_4539 crossref_primary_10_1007_s11010_023_04832_x crossref_primary_10_3389_fimmu_2021_654109 crossref_primary_10_1007_s42399_020_00262_8 crossref_primary_10_2139_ssrn_3937114 crossref_primary_10_1080_03009742_2019_1604992 crossref_primary_10_3389_fimmu_2020_01660 crossref_primary_10_3389_fimmu_2019_01156 crossref_primary_10_1002_bies_202100256 crossref_primary_10_1186_s12865_021_00407_x crossref_primary_10_3389_fimmu_2018_01892 crossref_primary_10_3389_fmolb_2023_1182512 crossref_primary_10_1038_nrrheum_2016_146 crossref_primary_10_1016_j_intimp_2021_108396 |
Cites_doi | 10.1371/journal.pgen.1000319 10.1136/heartjnl-2015-307734 10.2741/2096 10.1136/archdischild-2014-307536 10.1155/2012/935425 10.1016/j.autrev.2015.11.010 10.4049/jimmunol.155.3.1151 10.1016/S0065-2776(08)60801-9 10.1086/323155 10.1056/NEJMp068268 10.1016/0046-8177(90)90135-R 10.1002/art.39112 10.1002/art.37815 10.1002/(SICI)1097-0320(19990615)38:3<95::AID-CYTO1>3.0.CO;2-L 10.2169/internalmedicine.52.9463 10.1016/S1568-9972(02)00065-4 10.1038/sj.gene.6364225 10.1182/blood-2003-04-1320 10.1161/CIRCULATIONAHA.107.751404 10.1038/pr.2015.12 |
ContentType | Journal Article |
Copyright | 2016 Copyright © 2016. Published by Elsevier Inc. |
Copyright_xml | – notice: 2016 – notice: Copyright © 2016. Published by Elsevier Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 |
DOI | 10.1016/j.clim.2016.08.012 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1521-7035 |
EndPage | 31 |
ExternalDocumentID | 27519954 10_1016_j_clim_2016_08_012 1_s2_0_S1521661616302005 S1521661616302005 |
Genre | Clinical Trial Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29B 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABPPZ ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HX~ HZ~ IH2 IHE J1W K-O KOM L7B LG5 LUGTX M41 MO0 N9A O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SDP SES SEW SPCBC SSH SSZ T5K X7M XPP Y6R Z5R ZGI ZMT ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG SSI AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 |
ID | FETCH-LOGICAL-c442t-9e8d37810af04ae62bc0d01047ff6df53252e4c38d46b7cb2aba1f917984b0a73 |
ISSN | 1521-6616 1521-7035 |
IngestDate | Fri Jul 11 06:40:41 EDT 2025 Fri Jul 11 04:51:57 EDT 2025 Mon Jul 21 05:53:44 EDT 2025 Thu Apr 24 23:00:52 EDT 2025 Tue Jul 01 02:44:03 EDT 2025 Tue Feb 25 20:03:49 EST 2025 Tue Aug 26 16:33:56 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Flow cytometry Immune activation Kawasaki disease ROC curve CD8+HLA-DR+ T cells CD8 + HLA-DR + T cells |
Language | English |
License | Copyright © 2016. Published by Elsevier Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c442t-9e8d37810af04ae62bc0d01047ff6df53252e4c38d46b7cb2aba1f917984b0a73 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 27519954 |
PQID | 1835397193 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1837296235 proquest_miscellaneous_1835397193 pubmed_primary_27519954 crossref_citationtrail_10_1016_j_clim_2016_08_012 crossref_primary_10_1016_j_clim_2016_08_012 elsevier_clinicalkeyesjournals_1_s2_0_S1521661616302005 elsevier_clinicalkey_doi_10_1016_j_clim_2016_08_012 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-10-01 |
PublicationDateYYYYMMDD | 2016-10-01 |
PublicationDate_xml | – month: 10 year: 2016 text: 2016-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Clinical immunology (Orlando, Fla.) |
PublicationTitleAlternate | Clin Immunol |
PublicationYear | 2016 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Brown, Crawford, Cornwall, Garcia, Shulman, Rowley (bb0080) 2001; 184 Cosmi, Liotta, Lazzeri, Francalanci, Angeli, Mazzinghi (bb0105) 2003; 102 Rutella, Rumi, Lucia, Barberi, Puggioni, Lai (bb0125) 1999; 38 Burns, Shimizu, Shike, Newburger, Sundel, Baker (bb0055) 2005; 6 Starska, Glowacka, Kulig, Lewy-Trenda, Brys, Lewkowicz (bb0075) 2011; 49 Ohmoto-Sekine, Ishihara, Hsieh, Amakawa, Hara, Tsuji (bb0020) 2013; 52 Kawasaki (bb0005) 1967; 16 Filaci, Suciu-Foca (bb0115) 2002; 1 Fraison, Seve, Dauphin, Mahr, Gomard-Mennesson, Varron (bb0025) 2016; 15 Hartopo, Setianto (bb0030) 2013; 45 Keckler (bb0095) 2007; 12 Baker, Newburger (bb0015) 2008; 118 Burns (bb0045) 2007; 356 Sugawara (bb0085) 1991; 40 Tincati, Bellistri, Ancona, Merlini, Monforte, Marchetti (bb0070) 2012; 2012 Sakaguchi, Sakaguchi, Asano, Itoh, Toda (bb0100) 1995; 155 Ye, Shao, Shang, Zhang, Hu, Zhang (bb0035) 2015; 67 Singh, Vignesh, Burgner (bb0010) 2015; 100 Terai, Kohno, Namba, Umemiya, Niwa, Nakajima (bb0090) 1990; 21 Burgner, Davila, Breunis, Ng, Li, Bonnard (bb0050) 2009; 5 Bienvenu, Martin, Auffray, Cordier, Becourt, Lucas (bb0110) 1950; 175 Wakiguchi, Hasegawa, Suzuki, Kudo, Ichiyama (bb0120) 2015; 77 Shah, Christov, Mukasa, Brogan, Wade, Eleftheriou (bb0060) 2015; 101 Winchester, Kunkel (bb0065) 1979; 28 Wang, Wang, Gong, Fu, Zhang, Hu (bb0040) 2013; 65 Ohmoto-Sekine (10.1016/j.clim.2016.08.012_bb0020) 2013; 52 Wang (10.1016/j.clim.2016.08.012_bb0040) 2013; 65 Burns (10.1016/j.clim.2016.08.012_bb0045) 2007; 356 Hartopo (10.1016/j.clim.2016.08.012_bb0030) 2013; 45 Shah (10.1016/j.clim.2016.08.012_bb0060) 2015; 101 Baker (10.1016/j.clim.2016.08.012_bb0015) 2008; 118 Cosmi (10.1016/j.clim.2016.08.012_bb0105) 2003; 102 Wakiguchi (10.1016/j.clim.2016.08.012_bb0120) 2015; 77 Filaci (10.1016/j.clim.2016.08.012_bb0115) 2002; 1 Starska (10.1016/j.clim.2016.08.012_bb0075) 2011; 49 Burgner (10.1016/j.clim.2016.08.012_bb0050) 2009; 5 Winchester (10.1016/j.clim.2016.08.012_bb0065) 1979; 28 Brown (10.1016/j.clim.2016.08.012_bb0080) 2001; 184 Singh (10.1016/j.clim.2016.08.012_bb0010) 2015; 100 Ye (10.1016/j.clim.2016.08.012_bb0035) 2015; 67 Kawasaki (10.1016/j.clim.2016.08.012_bb0005) 1967; 16 Sakaguchi (10.1016/j.clim.2016.08.012_bb0100) 1995; 155 Terai (10.1016/j.clim.2016.08.012_bb0090) 1990; 21 Sugawara (10.1016/j.clim.2016.08.012_bb0085) 1991; 40 Keckler (10.1016/j.clim.2016.08.012_bb0095) 2007; 12 Rutella (10.1016/j.clim.2016.08.012_bb0125) 1999; 38 Fraison (10.1016/j.clim.2016.08.012_bb0025) 2016; 15 Burns (10.1016/j.clim.2016.08.012_bb0055) 2005; 6 Tincati (10.1016/j.clim.2016.08.012_bb0070) 2012; 2012 Bienvenu (10.1016/j.clim.2016.08.012_bb0110) 1950; 175 27558657 - Nat Rev Rheumatol. 2016 Oct;12(10):562 |
References_xml | – volume: 67 start-page: 1943 year: 2015 end-page: 1950 ident: bb0035 article-title: A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease publication-title: Arthritis Rheum. (Hoboken, N.J.) – volume: 5 year: 2009 ident: bb0050 article-title: A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease publication-title: PLoS Genet. – volume: 155 start-page: 1151 year: 1995 end-page: 1164 ident: bb0100 article-title: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases publication-title: J. Immunol. (Baltimore, Md.: 1950) – volume: 356 start-page: 659 year: 2007 end-page: 661 ident: bb0045 article-title: The riddle of Kawasaki disease publication-title: N. Engl. J. Med. – volume: 21 start-page: 231 year: 1990 end-page: 234 ident: bb0090 article-title: Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease publication-title: Hum. Pathol. – volume: 40 start-page: 476 year: 1991 end-page: 482 ident: bb0085 article-title: Immunopathology of skin lesions in Kawasaki disease publication-title: Arerugi – volume: 49 start-page: 579 year: 2011 end-page: 592 ident: bb0075 article-title: The role of tumor cells in the modification of T lymphocytes activity–the expression of the early CD69 publication-title: Part I, Folia histochemica et cytobiologica/Polish Academy of Sciences – volume: 45 start-page: 69 year: 2013 end-page: 75 ident: bb0030 article-title: Coronary artery sequel of Kawasaki disease in adulthood, a concern for internists and cardiologists publication-title: Acta Medica Indonesiana – volume: 38 start-page: 95 year: 1999 end-page: 101 ident: bb0125 article-title: Induction of CD69 antigen on normal CD4 publication-title: Cytometry – volume: 175 start-page: 246 year: 1950 end-page: 253 ident: bb0110 article-title: Peripheral CD8 publication-title: J. Immunol. (Baltimore: Md. – volume: 1 start-page: 279 year: 2002 end-page: 283 ident: bb0115 article-title: CD8 publication-title: Autoimmun. Rev. – volume: 100 start-page: 1084 year: 2015 end-page: 1088 ident: bb0010 article-title: The epidemiology of Kawasaki disease: a global update publication-title: Arch. Dis. Child. – volume: 15 start-page: 242 year: 2016 end-page: 249 ident: bb0025 article-title: Kawasaki disease in adults: observations in France and literature review publication-title: Autoimmun. Rev. – volume: 2012 start-page: 935425 year: 2012 ident: bb0070 article-title: Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients publication-title: Clin. Dev. Immunol. – volume: 118 start-page: e110 year: 2008 end-page: e112 ident: bb0015 article-title: Cardiology patient pages. Kawasaki disease publication-title: Circulation – volume: 77 start-page: 536 year: 2015 end-page: 540 ident: bb0120 article-title: Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease publication-title: Pediatr. Res. – volume: 101 start-page: 1646 year: 2015 end-page: 1655 ident: bb0060 article-title: Cardiovascular status after Kawasaki disease in the UK publication-title: Heart – volume: 12 start-page: 725 year: 2007 end-page: 732 ident: bb0095 article-title: Dodging the CTL response: viral evasion of Fas and granzyme induced apoptosis publication-title: Front. Biosci. – volume: 65 start-page: 805 year: 2013 end-page: 814 ident: bb0040 article-title: Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease publication-title: Arthritis Rheum. – volume: 28 start-page: 221 year: 1979 end-page: 292 ident: bb0065 article-title: The human Ia system publication-title: Adv. Immunol. – volume: 52 start-page: 977 year: 2013 end-page: 980 ident: bb0020 article-title: Giant coronary artery aneurysms associated with Kawasaki disease detected on whole-heart magnetic resonance coronary angiographic screening publication-title: Intern. Med. (Tokyo, Japan) – volume: 184 start-page: 940 year: 2001 end-page: 943 ident: bb0080 article-title: CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease publication-title: J. Infect. Dis. – volume: 16 start-page: 178 year: 1967 end-page: 222 ident: bb0005 article-title: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children publication-title: Arerugi – volume: 102 start-page: 4107 year: 2003 end-page: 4114 ident: bb0105 article-title: Human CD8 publication-title: Blood – volume: 6 start-page: 438 year: 2005 end-page: 444 ident: bb0055 article-title: Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease publication-title: Genes Immun. – volume: 5 year: 2009 ident: 10.1016/j.clim.2016.08.012_bb0050 article-title: A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1000319 – volume: 101 start-page: 1646 year: 2015 ident: 10.1016/j.clim.2016.08.012_bb0060 article-title: Cardiovascular status after Kawasaki disease in the UK publication-title: Heart doi: 10.1136/heartjnl-2015-307734 – volume: 45 start-page: 69 year: 2013 ident: 10.1016/j.clim.2016.08.012_bb0030 article-title: Coronary artery sequel of Kawasaki disease in adulthood, a concern for internists and cardiologists publication-title: Acta Medica Indonesiana – volume: 12 start-page: 725 year: 2007 ident: 10.1016/j.clim.2016.08.012_bb0095 article-title: Dodging the CTL response: viral evasion of Fas and granzyme induced apoptosis publication-title: Front. Biosci. doi: 10.2741/2096 – volume: 49 start-page: 579 year: 2011 ident: 10.1016/j.clim.2016.08.012_bb0075 article-title: The role of tumor cells in the modification of T lymphocytes activity–the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma – volume: 100 start-page: 1084 year: 2015 ident: 10.1016/j.clim.2016.08.012_bb0010 article-title: The epidemiology of Kawasaki disease: a global update publication-title: Arch. Dis. Child. doi: 10.1136/archdischild-2014-307536 – volume: 2012 start-page: 935425 year: 2012 ident: 10.1016/j.clim.2016.08.012_bb0070 article-title: Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients publication-title: Clin. Dev. Immunol. doi: 10.1155/2012/935425 – volume: 15 start-page: 242 year: 2016 ident: 10.1016/j.clim.2016.08.012_bb0025 article-title: Kawasaki disease in adults: observations in France and literature review publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2015.11.010 – volume: 155 start-page: 1151 year: 1995 ident: 10.1016/j.clim.2016.08.012_bb0100 article-title: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases publication-title: J. Immunol. (Baltimore, Md.: 1950) doi: 10.4049/jimmunol.155.3.1151 – volume: 28 start-page: 221 year: 1979 ident: 10.1016/j.clim.2016.08.012_bb0065 article-title: The human Ia system publication-title: Adv. Immunol. doi: 10.1016/S0065-2776(08)60801-9 – volume: 184 start-page: 940 year: 2001 ident: 10.1016/j.clim.2016.08.012_bb0080 article-title: CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease publication-title: J. Infect. Dis. doi: 10.1086/323155 – volume: 356 start-page: 659 year: 2007 ident: 10.1016/j.clim.2016.08.012_bb0045 article-title: The riddle of Kawasaki disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp068268 – volume: 21 start-page: 231 year: 1990 ident: 10.1016/j.clim.2016.08.012_bb0090 article-title: Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease publication-title: Hum. Pathol. doi: 10.1016/0046-8177(90)90135-R – volume: 67 start-page: 1943 year: 2015 ident: 10.1016/j.clim.2016.08.012_bb0035 article-title: A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease publication-title: Arthritis Rheum. (Hoboken, N.J.) doi: 10.1002/art.39112 – volume: 65 start-page: 805 year: 2013 ident: 10.1016/j.clim.2016.08.012_bb0040 article-title: Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease publication-title: Arthritis Rheum. doi: 10.1002/art.37815 – volume: 175 start-page: 246 issue: 2005 year: 1950 ident: 10.1016/j.clim.2016.08.012_bb0110 article-title: Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity publication-title: J. Immunol. (Baltimore: Md. – volume: 16 start-page: 178 year: 1967 ident: 10.1016/j.clim.2016.08.012_bb0005 article-title: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children publication-title: Arerugi=[Allergy] – volume: 38 start-page: 95 year: 1999 ident: 10.1016/j.clim.2016.08.012_bb0125 article-title: Induction of CD69 antigen on normal CD4+ and CD8+ lymphocyte subsets and its relationship with the phenotype of responding T-cells publication-title: Cytometry doi: 10.1002/(SICI)1097-0320(19990615)38:3<95::AID-CYTO1>3.0.CO;2-L – volume: 52 start-page: 977 year: 2013 ident: 10.1016/j.clim.2016.08.012_bb0020 article-title: Giant coronary artery aneurysms associated with Kawasaki disease detected on whole-heart magnetic resonance coronary angiographic screening publication-title: Intern. Med. (Tokyo, Japan) doi: 10.2169/internalmedicine.52.9463 – volume: 40 start-page: 476 year: 1991 ident: 10.1016/j.clim.2016.08.012_bb0085 article-title: Immunopathology of skin lesions in Kawasaki disease publication-title: Arerugi=[Allergy] – volume: 1 start-page: 279 year: 2002 ident: 10.1016/j.clim.2016.08.012_bb0115 article-title: CD8+ T suppressor cells are back to the game: are they players in autoimmunity? publication-title: Autoimmun. Rev. doi: 10.1016/S1568-9972(02)00065-4 – volume: 6 start-page: 438 year: 2005 ident: 10.1016/j.clim.2016.08.012_bb0055 article-title: Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease publication-title: Genes Immun. doi: 10.1038/sj.gene.6364225 – volume: 102 start-page: 4107 year: 2003 ident: 10.1016/j.clim.2016.08.012_bb0105 article-title: Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes publication-title: Blood doi: 10.1182/blood-2003-04-1320 – volume: 118 start-page: e110 year: 2008 ident: 10.1016/j.clim.2016.08.012_bb0015 article-title: Cardiology patient pages. Kawasaki disease publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.751404 – volume: 77 start-page: 536 year: 2015 ident: 10.1016/j.clim.2016.08.012_bb0120 article-title: Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease publication-title: Pediatr. Res. doi: 10.1038/pr.2015.12 – reference: 27558657 - Nat Rev Rheumatol. 2016 Oct;12(10):562 |
SSID | ssj0005226 |
Score | 2.3235395 |
Snippet | Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in adults.... Abstract Kawasaki disease (KD) has become the most common cause of acquired heart disease in children and is also a risk factor for ischemic heart disease in... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 25 |
SubjectTerms | Allergy and Immunology CD4-Positive T-Lymphocytes - immunology CD8 + HLA-DR + T cells CD8-Positive T-Lymphocytes - immunology Child Child, Preschool Female Flow cytometry Humans Immune activation Immunoglobulins, Intravenous - pharmacology Immunoglobulins, Intravenous - therapeutic use Immunologic Factors - pharmacology Immunologic Factors - therapeutic use Infant Kawasaki disease Lymphocyte Activation Male Mucocutaneous Lymph Node Syndrome - drug therapy Mucocutaneous Lymph Node Syndrome - immunology ROC curve T-Lymphocyte Subsets - immunology Treatment Outcome |
Title | Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1521661616302005 https://www.clinicalkey.es/playcontent/1-s2.0-S1521661616302005 https://www.ncbi.nlm.nih.gov/pubmed/27519954 https://www.proquest.com/docview/1835397193 https://www.proquest.com/docview/1837296235 |
Volume | 171 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5FRUJcEG_CS4sEp8iRvV6vnSMUogAqEiKVymm1L9NUUQJNQiUOnPnZzL4cm7YR9BIlltePzOfZmc8z3yL0oqAkrXOWJVVByoQakydiJPJEa4h3NaGVcgKmBx_Z5JC-PyqOer3fraqlzVoO1c8L-0quYlXYBna1XbL_YdnmoLABvoN94RMsDJ__ZON3lpn94VVWZ7bRY2n1PVxt-baA_DRUwQav5le9jS8J4Cck3I432H9TvSSvB9OB5fKdxoZnay0j8kGciRXEmp33OVHfIPZW-itwkk5Ww9R1ETsidjwXwxbj8MVxqJ_inOnE-b3HGYvF1-T7rGF9GjL7eAabxXbAZOPQF6EdWIuMNfVvgUqL7TSdak8bSyQQMLCOe_ZLtEQHW7Smaj9_nJsEPB9xMlTzmdUayJgTaQ3V2l1x7c_2lPaMEJamXgz3GoGEw3rM4a92sZBbuK-5wNB-5SsF_z7PZSHOZSmMC2Wmt9DNkIPgVx5Qt1HPLO6g6wehyuIuOmvhCndxhRtc4S6ucMAVXsI-xwZ7XOFljQFXAzzFFlV4iyoMx4qowgFV99Dh-O10f5KEBToSRSlZJyNT6bysslTUKRWGEalS7QSf6prpushJQQxVeaUpk6WSREiR1SOrkUdlKsr8PtpbLBfmIcJMyNRArCp0SajKiKyrvFJSF6xWekRMH2XxP-UqqNfbRVTmPJYpnnBrB27twO3Kqhnpo0Ez5pvXbtm5dx5NxWNXMsyjHFC1c1R50SizCm5ixTO-Ijzl55DWR88jHji4dGsFsTBgWA6zbAFpAqRWO_eBtBhyFzjOAw-m5h5JWVjhBfroSnf0GN3YPrBP0N76dGOeQuC9ls_cM_EH77zYvw |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intravenous+immunoglobulin+treatment+responsiveness+depends+on+the+degree+of+CD8%2B+T+cell+activation+in+Kawasaki+disease&rft.jtitle=Clinical+immunology+%28Orlando%2C+Fla.%29&rft.au=Ye%2C+Qing&rft.au=Gong%2C+Fang-qi&rft.au=Shang%2C+Shi-qiang&rft.au=Hu%2C+Jian&rft.date=2016-10-01&rft.pub=Elsevier+Inc&rft.issn=1521-6616&rft.volume=171&rft.spage=25&rft.epage=31&rft_id=info:doi/10.1016%2Fj.clim.2016.08.012&rft.externalDocID=S1521661616302005 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1521-6616&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1521-6616&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1521-6616&client=summon |